Weighted Average Number of Shares Outstanding, Diluted of LEXICON PHARMACEUTICALS, INC. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
LEXICON PHARMACEUTICALS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • LEXICON PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 363,053,000, a 13% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 363,053,000, a 13% increase from 2024.
  • LEXICON PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 320,031,000, a 45% increase from 2023.
  • LEXICON PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 221,130,000, a 33% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 363,053,000 +43,022,000 +13% 01 Oct 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 363,399,000 +1,907,000 +0.53% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 363,570,000 +52,734,000 +17% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 362,073,000 +116,683,000 +48% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 320,031,000 +98,901,000 +45% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 361,492,000 +116,567,000 +48% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 310,836,000 +106,053,000 +52% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 245,390,000 +56,376,000 +30% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 221,130,000 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2026 2025 FY
Q3 2023 244,925,000 +70,021,000 +40% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 204,783,000 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 189,014,000 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q3 2022 174,904,000 +29,084,000 +20% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q3 2021 145,820,000 +28,268,000 +24% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q3 2020 117,552,000 +912,000 +0.78% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q4 2019 106,272,000 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2020 2019 FY
Q3 2019 116,640,000 +10,759,000 +10% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 106,272,000 01 Apr 2019 30 Jun 2019 10-K 12 Mar 2020 2019 FY
Q1 2019 106,054,000 01 Jan 2019 31 Mar 2019 10-K 12 Mar 2020 2019 FY
Q3 2018 105,881,000 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q4 2015 115,764,000 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2017 2016 FY
Q3 2015 103,616,000 01 Jul 2015 30 Sep 2015 10-K 06 Mar 2017 2016 FY
Q2 2015 103,608,000 01 Apr 2015 30 Jun 2015 10-K 06 Mar 2017 2016 FY
Q1 2015 103,516,000 01 Jan 2015 31 Mar 2015 10-K 06 Mar 2017 2016 FY

LEXICON PHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 363,053,000 +43,022,000 +13% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 320,031,000 +98,901,000 +45% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 221,130,000 +55,397,000 +33% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2026 2025 FY
2022 165,733,000 +20,081,000 +14% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025 2024 FY
2021 145,652,000 +34,811,000 +31% 01 Jan 2021 31 Dec 2021 10-K 25 Mar 2024 2023 FY
2020 110,841,000 -5,906,000 -5.1% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2019 FY
2019 116,747,000 +10,917,000 +10% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2019 FY
2018 105,830,000 +593,000 +0.56% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2019 FY
2017 105,237,000 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.